Skip to main content
. 2020 Sep 10;5(1):121–137. doi: 10.1016/j.jseint.2020.07.018

Table V.

Number of fractures treated conservatively and fracture rates stratified by diagnosis and prosthesis design

Number of Fx treated conservatively Rate, % (n/n)
Intraop. humerus Fx 52 53.6 (52/97)
Intraop. glenoid Fx 10 66.7 (10/15)
Postop. humerus Fx 25 36.2 (25/69)
Postop. glenoid Fx
3
50 (3/6)
Diagnosis
CTA
RCT
PHF
Failed arthroplasty
Shoulders 990 247 1443 1290
Intraop. humerus Fx 0.3 (3/990) 0 (0/247) 0.8 (11/1443) 5.5 (71/1290)
Intraop. glenoid Fx 0.3 (3/990) 0 (0/247) 0.1 (2/1443) 0.2 (3/1290)
Postop. humerus Fx 0.2 (2/990) 0.8 (2/247) 0.5 (7/1443) 2.6 (33/1290)
Postop. glenoid Fx
0.2 (2/990)
0 (0/247)
0 (0/1443)
0 (0/1290)
Prosthesis design
LG/MH
MG/LH
LG/LH
MG/MH
Shoulders 711 318 28 2839
Intraop. humerus Fx 0 (0/711) 0 (0/318) 0 (0/28) 1.6 (46/2839)
Intraop. glenoid Fx 0 (0/711) 0.3 (1/318) 0 (0/28) 0.1 (3/2839)
Postop. humerus Fx 2.1 (15/711) 2.5 (8/318) 0 (0/28) 1.1 (31/2839)§
Postop. glenoid Fx 0 (0/711) 0.3 (1/318) 0 (0/28) 0.2 (5/2839)

Intraop., intraoperatively; Postop., postoperatively; Fx, fracture; CTA, cuff tear arthropathy; RCT, rotator cuff tear; PHF, proximal humerus fracture; LG, lateralized glenoid; MH, medialized humerus; MG, medialized glenoid; LH, lateralized humerus.

P < .001 vs. CTA; P < .001 vs. RCT; P < .001 vs. PHF.

P < .001 vs. CTA; P = .09 vs. RCT; P < .001 vs. PHF.

P = .001 vs. LG/MH.

§

P = .03 vs. MG/LH; P = .03 vs. LG/MH.